Effect of fluconazole dose on the extent of fluconazole-triazolam interaction

British Journal of Clinical Pharmacology

Volumn 42, Issue 4, 1996, Pages 465-470

  Varhe, Anu ^a   Olkkola, Klaus T ^a   Neuvonen, Pertti J ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

Author keywords

dose dependent; fluconazole; interaction; triazolam

Indexed keywords

FLUCONAZOLE; PLACEBO; TRIAZOLAM;

ADULT; AREA UNDER THE CURVE; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG BLOOD LEVEL; DRUG ELIMINATION; DRUG HALF LIFE; DRUG METABOLISM; DRUG POTENTIATION; FEMALE; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PHARMACODYNAMICS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; VOLUNTEER;

EID: 0029798201     PISSN: 03065251     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2125.1996.tb00009.x     Document Type: Article

References (16)

1. Kronbach T, Mathys D, Umeno M, Gonzales FJ, Meyer UA. Oxidation of midazolam and triazolam by human liver cytochrome P450IIIA4. Mol Pharmacol 1989; 36: 89-96.
2. Varhe A, Olkkola KT, Neuvonen PJ. Fluconazole, but not terbinafine, interacts with triazolam. Br J Clin Pharmacol 1996; 41: 319-323.
3. Varhe A, Olkkola KT, Neuvonen PJ. Oral triazolam is potentially hazardous to patients receiving systemic antimycotics ketoconazole or itraconazole. Clin Pharmacol Ther 1994; 56: 601-607.
4. De Kroon IFI, Langendijk PNJ, De Goede PNFC. Simultaneous determination of midazolam and its three hydroxy metabolites in human plasma by electron-capture gas chromatography without derivatization. J Chromatogr 1989; 491: 107-116.
5. Gaillard Y, Gay-Montchamp J-P, Ollagnier M. Simultaneous screening and quantitation of alpidem, zolpidem, buspirone and benzodiazepines by dual-channel gas chromatography using electron-capture and nitrogen-phosphorus detection after solid-phase extraction. J Chromatogr 1993; 622: 197-208.
6. Harris SC, Wallace JE, Foulds G, Rinaldi MG. Assay of fluconazole by Megabore Capillary Gas-Liquid Chromatography with Nitrogen-Selective Detection. Antimicrobial Agents Chemother 1989; 33: 714-716.
7. Lopez-Gill JA. Fluconazole-cyclosporine interaction: a dose dependent effect? Ann Pharmacother 1993; 27: 427-430.
8. Honig PK, Wortham DC, Zamani K, Mullin JL, Conner DP, Cantilena LR. The effect of fluconazole on the steady-state pharmacokinetics and electrocardiographic pharmacodynamics of terfenadine in humans. Clin Pharmncol Ther 1993; 53: 630-636.
9. Cantilena LR, Sorrels S, Wiley T, Wortham D. Fluconazole alters terfenadine pharmacokinetics and electrocardiographic pharmacodynamics. Clin Pharmacol Ther 1995; 57: 185. [Abstract]
10. Honig PK, Wortham DC, Zamani K, Conner DP, Mullin JL, Cantilena LR. Terfenadine-keloconazole interaction: pharmacokinetic and electrocardiographic consequences. JAMA 1993; 269: 1513-1518.
11. Pohjola-Sintonen S, Viitasalo M, Toivonen L, Neuvonen PJ. Itraconazole prevents terfenadine metabolism and increases risk of torsades de pointes ventricular tachycardia. Eur J Clin Pharmacol 1993; 45: 191-193.
12. Olkkola KT, Ahonen J, Neuvonen PJ. The effect of the systemic antimycotics, itraconazole and fluconazole, on the pharmacokinetics and pharmacodynamics of intravenous and oral midazolam. Anesth Analg 1996; 82: 511-516.
13. Hargreaves JA, Jezequel S, Houston JB. Effect of azole antifungals on human microsomal metabolism of diclofenac and midazolam. Br J Clin Pharmacol 1994; 38: 175P. [Abstract]
14. Grant SM, Clissold SP. Fluconazole: a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in superficial and systemic mycoses. Drugs 1990; 39: 877-916.
15. Arredondo G, Calvo R, Marcos F, Martinez-Jordá R, Suarez E. Protein binding of itraconazole and fluconazole in patients with cancer, Int J Clin Pharmacol Ther 1995; 33: 449-452.
16. Ervine CM, Houston JB. Disposition of azole antifungal agents. III. Binding of fluconazole and other azoles in rat liver. Pharm Res 1994; 11: 961-965.